Search Results: PARP

• Policy & Insight
• Science & Technology

Expert Opinion: Professor Nic Jones

11 March 2011

• Health & Medicine

Cancer Research Technology, The ICR and ZoBio BV sign deal to develop cancer drugs

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival. Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) have signed a deal with Dutch drug discovery company, ZoBio BV, to discover and develop drugs to block a DNA repair target which may play a role in cancer cell survival.

10 March 2011

• Health & Medicine

Ovarian cancer survival doubles in 30 years

Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today. Survival from ovarian cancer has almost doubled over the last 30 years according to new figures from Cancer Research UK released today.

9 March 2011

• Health & Medicine

Two-pronged approach brings hope for bowel cancer treatment

Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research. Cancer Research UK-funded scientists have discovered that blocking two cell DNA repair routes at once could provide a completely new way to treat bowel cancer and potentially other cancers, according to research published in Cancer Research.

1 March 2011

• Science & Technology

New breast cancer ‘accelerator’ gene tracked down

18 February 2011

• Science & Technology
• Health & Medicine

2010 - A year of progress

17 December 2010

Cancer Research UK announce recipients of inaugural Prizes

The first ever Cancer Research UK prizes were presented this week at the National Cancer Research Institute Cancer Conference in Liverpool. The first ever Cancer Research UK prizes were presented this week at the National Cancer Research Institute Cancer Conference in Liverpool.

10 November 2010

• Health & Medicine
• Science & Technology

NCRI conference: making progress in treating ovarian cancer

8 November 2010

• Health & Medicine

Test selects the 60 per cent of women with inherited ovarian cancer who could benefit from 'smart' drug

Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool. Scientists have developed a new test to select which patients with ovarian cancer will benefit from new drugs called PARP inhibitors, according to research presented at the NCRI Cancer Conference in Liverpool.

8 November 2010

• Science & Technology
• Health & Medicine

International drug trials underline the future of cancer treatment

18 August 2010

• Science & Technology

Gene study backs promise of breast cancer drugs to treat hereditary prostate cancer

How prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation How prostate cancer develops in men who have an altered 'breast cancer gene' is the same route by which breast cancer develops in women with the same mutation

24 June 2010

Edinburgh launches new cancer research centre

Edinburgh today (Wednesday) becomes the next link in a unique chain of Cancer Research UK Centres that are being launched across the UK. Edinburgh today (Wednesday) becomes the next link in a unique chain of Cancer Research UK Centres that are being launched across the UK.

16 June 2010